Mixed-use development
Appears in 2 stories · Last updated Oct 30, 2026
Markets pembrolizumab (Keytruda), the control arm and combination partner in the AHEAD-MERIT trial
BioNTech's mRNA cancer drug BNT113, added to Merck's Keytruda, did not hold off HPV16-positive head and neck cancer longer than Keytruda alone. The miss, reported Oct. 13, was the first of the Phase 2/3 AHEAD-MERIT trial's two main goals, and US-listed BioNTech shares fell about 7% that day.
Updated Oct 30
As of September 2026: Under construction, Park Golf is first tenant
Park Golf Pitch and Putt secured a Texas alcohol license on August 20 for its venue at 6006 UTSA Boulevard in San Antonio. The license covers alcohol sales at this address.
Updated Sep 11
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
